Ascertaining an Appropriate Diagnostic Algorithm Using EGFR Mutation-Specific Antibodies to Detect EGFR Status in Non-Small-Cell Lung Cancer

BACKGROUND: Epidermal growth factor receptor (EGFR) mutation status is the most valuable indicator in the screening of non-small-cell lung cancer (NSCLC) patients for tyrosine kinase inhibitor (TKI) therapy. Accurate, rapid and economical methods of detecting EGFR mutations have become important. Th...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Guiyang, Fan, Chuifeng, Zhang, Xiupeng, Dong, Qianze, Wang, Liang, Liu, Yang, Dai, Shundong, Yang, Lianhe, Zhang, Yong, Yu, Juanhan, Wang, Enhua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3594188/
https://www.ncbi.nlm.nih.gov/pubmed/23536868
http://dx.doi.org/10.1371/journal.pone.0059183

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3594188/
https://www.ncbi.nlm.nih.gov/pubmed/23536868
http://dx.doi.org/10.1371/journal.pone.0059183

Ejemplares similares